RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection

被引:414
作者
Hu, Wenhui [1 ,2 ]
Kaminski, Rafal [1 ,2 ]
Yang, Fan [1 ,2 ]
Zhang, Yonggang [1 ,2 ]
Cosentino, Laura [1 ,2 ]
Li, Fang [1 ,2 ]
Luo, Biao [3 ]
Alvarez-Carbonell, David [4 ]
Garcia-Mesa, Yoelvis [4 ]
Karn, Jonathan [4 ]
Mo, Xianming [5 ]
Khalili, Kamel [1 ,2 ]
机构
[1] Temple Univ, Ctr Neurovirol, Sch Med, Philadelphia, PA 19140 USA
[2] Temple Univ, Comprehens NeuroAIDS Ctr, Sch Med, Philadelphia, PA 19140 USA
[3] Temple Univ, Fox Chase Canc Ctr, Sch Med, Canc Genome Inst, Philadelphia, PA 19111 USA
[4] Case Western Reserve Univ, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA
[5] Sichuan Univ, West China Hosp, West China Med Sch, State Key Lab Biotherapy,Lab Stem Cell Biol, Chengdu 610064, Peoples R China
基金
美国国家卫生研究院;
关键词
CRISPR/Cas9; genome editing; latency; retrovirus; reservoir; ZINC-FINGER-NUCLEASES; IMMUNODEFICIENCY-VIRUS TYPE-1; HEMATOPOIETIC STEM; HUMAN-CELLS; T-CELLS; GUIDED ENDONUCLEASE; IN-VITRO; CAS9; DNA; CCR5;
D O I
10.1073/pnas.1405186111
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
AIDS remains incurable due to the permanent integration of HIV-1 into the host genome, imparting risk of viral reactivation even after antiretroviral therapy. New strategies are needed to ablate the viral genome from latently infected cells, because current methods are too inefficient and prone to adverse off-target effects. To eliminate the integrated HIV-1 genome, we used the Cas9/guide RNA (gRNA) system, in single and multiplex configurations. We identified highly specific targets within the HIV-1 LTR U3 region that were efficiently edited by Cas9/gRNA, inactivating viral gene expression and replication in latently infected microglial, promonocytic, and T cells. Cas9/gRNAs caused neither genotoxicity nor off-target editing to the host cells, and completely excised a 9,709-bp fragment of integrated proviral DNA that spanned from its 5' to 3' LTRs. Furthermore, the presence of multiplex gRNAs within Cas9-expressing cells prevented HIV-1 infection. Our results suggest that Cas9/gRNA can be engineered to provide a specific, efficacious prophylactic and therapeutic approach against AIDS.
引用
收藏
页码:11461 / 11466
页数:6
相关论文
共 44 条
[1]  
[Anonymous], GLOB REP UNAIDS REP
[2]   Cut Site Selection by the Two Nuclease Domains of the Cas9 RNA-guided Endonuclease [J].
Chen, Hongfan ;
Choi, Jihoon ;
Bailey, Scott .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (19) :13284-13294
[3]   Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases [J].
Cho, Seung Woo ;
Kim, Sojung ;
Kim, Yongsub ;
Kweon, Jiyeon ;
Kim, Heon Seok ;
Bae, Sangsu ;
Kim, Jin-Soo .
GENOME RESEARCH, 2014, 24 (01) :132-141
[4]   Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease [J].
Cho, Seung Woo ;
Kim, Sojung ;
Kim, Jong Min ;
Kim, Jin-Soo .
NATURE BIOTECHNOLOGY, 2013, 31 (03) :230-232
[5]   HIV reservoirs: pathogenesis and obstacles to viral eradication and cure [J].
Chun, Tae-Wook ;
Fauci, Anthony S. .
AIDS, 2012, 26 (10) :1261-1268
[6]   Quantification of latent tissue reservoirs and total body viral load in HIV-1 Infection [J].
Chun, TW ;
Carruth, L ;
Finzi, D ;
Shen, XF ;
DiGiuseppe, JA ;
Taylor, H ;
Hermankova, M ;
Chadwick, K ;
Margolick, J ;
Quinn, TC ;
Kuo, YH ;
Brookmeyer, R ;
Zeiger, MA ;
BarditchCrovo, P ;
Siliciano, RF .
NATURE, 1997, 387 (6629) :183-188
[7]   Multiplex Genome Engineering Using CRISPR/Cas Systems [J].
Cong, Le ;
Ran, F. Ann ;
Cox, David ;
Lin, Shuailiang ;
Barretto, Robert ;
Habib, Naomi ;
Hsu, Patrick D. ;
Wu, Xuebing ;
Jiang, Wenyan ;
Marraffini, Luciano A. ;
Zhang, Feng .
SCIENCE, 2013, 339 (6121) :819-823
[8]   CRISPR/Cas9 systems targeting β-globin and CCR5 genes have substantial off-target activity [J].
Cradick, Thomas J. ;
Fine, Eli J. ;
Antico, Christopher J. ;
Bao, Gang .
NUCLEIC ACIDS RESEARCH, 2013, 41 (20) :9584-9592
[9]   Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120 [J].
Derdeyn, CA ;
Decker, JM ;
Sfakianos, JN ;
Wu, XY ;
O'Brien, WA ;
Ratner, L ;
Kappes, JC ;
Shaw, GM ;
Hunter, E .
JOURNAL OF VIROLOGY, 2000, 74 (18) :8358-8367
[10]   Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus [J].
Ebina, Hirotaka ;
Misawa, Naoko ;
Kanemura, Yuka ;
Koyanagi, Yoshio .
SCIENTIFIC REPORTS, 2013, 3